Access to Hepatitis C treatment in the USA has improved a little in the past few years as the availability of generic Hepatitis C medication has forced the big pharmaceutical companies to reduce their prices to about US$25,000 per treatment instead of the $50,000 to $100,000 range that has existed in the USA since Solvadi was first launched in 2014.

The prices for Hepatitis C treatment in the USA have dropped because of people like Robert, whose story I am sharing below. US citizens like Robert had the courage to take personal control of their health and to step outside of the USA’s corrupted health system to cure Hepatitis C using generic Hepatitis C medication.

Robert has gone a step further and shared his story so that people with Hepatitis C in the USA and other countries can get an idea of just how simple it is to take control of one’s own health.

Click here to read the rest of this story about Robert’s refusal to take no for an answer and his determination to take his health in his own hands. This excerpt from Greg’s blog is reprinted with permission, and the views are entirely his.